News on Ablynx nv from BioPortfolio.com http://www.BioPortfolio.com Consolidated Ablynx nv news from BioPortfolio.com Wed, 10 Feb 2010 15:53:12 GMT en Ablynx aims to launch llama-based arthritis drug in 2013http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3963612&HITNO=0&MSIZE=24&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Ablynx%20nv&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3963612&THISHREF=http://c.moreover.com/click/here.pl%3fz2497796579%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3963612&HITNO=0&MSIZE=24&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Ablynx%20nv&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3963612&THISHREF=http://c.moreover.com/click/here.pl%3fz2497796579%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comSmartBrief: Ablynx says first nanobody drug may hit market by 2013http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3955518&HITNO=1&MSIZE=24&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Ablynx%20nv&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3955518&THISHREF=http://c.moreover.com/click/here.pl%3fz2494073576%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3955518&HITNO=1&MSIZE=24&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Ablynx%20nv&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3955518&THISHREF=http://c.moreover.com/click/here.pl%3fz2494073576%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comSharenet: CORRECTED-Ablynx says first nanobody drug may hit market by 2013http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3955855&HITNO=2&MSIZE=24&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Ablynx%20nv&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3955855&THISHREF=http://c.moreover.com/click/here.pl%3fz2494303316%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3955855&HITNO=2&MSIZE=24&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Ablynx%20nv&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3955855&THISHREF=http://c.moreover.com/click/here.pl%3fz2494303316%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comReuters UK: CORRECTED-Ablynx says first nanobody drug may hit market by 2013http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3955607&HITNO=3&MSIZE=24&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Ablynx%20nv&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3955607&THISHREF=http://c.moreover.com/click/here.pl%3fz2494124781%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3955607&HITNO=3&MSIZE=24&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Ablynx%20nv&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3955607&THISHREF=http://c.moreover.com/click/here.pl%3fz2494124781%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comReuters: CORRECTED-Ablynx says first nanobody drug may hit market by 2013http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3955585&HITNO=4&MSIZE=24&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Ablynx%20nv&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3955585&THISHREF=http://c.moreover.com/click/here.pl%3fz2494097330%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3955585&HITNO=4&MSIZE=24&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Ablynx%20nv&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3955585&THISHREF=http://c.moreover.com/click/here.pl%3fz2494097330%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comInteractive Investor: CORRECTED-Ablynx says first nanobody drug may hit market by 2013http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3955577&HITNO=5&MSIZE=24&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Ablynx%20nv&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3955577&THISHREF=http://c.moreover.com/click/here.pl%3fz2494094514%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3955577&HITNO=5&MSIZE=24&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Ablynx%20nv&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3955577&THISHREF=http://c.moreover.com/click/here.pl%3fz2494094514%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comFinanzNachrichten.de: CORRECTED-Ablynx says first nanobody drug may hit market by 2013http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3955720&HITNO=6&MSIZE=24&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Ablynx%20nv&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3955720&THISHREF=http://c.moreover.com/click/here.pl%3fz2494216059%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3955720&HITNO=6&MSIZE=24&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Ablynx%20nv&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3955720&THISHREF=http://c.moreover.com/click/here.pl%3fz2494216059%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comReuters India: Ablynx says first nanobody drug may hit mkt in 2013http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3949829&HITNO=7&MSIZE=24&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Ablynx%20nv&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3949829&THISHREF=http://c.moreover.com/click/here.pl%3fz2489336257%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3949829&HITNO=7&MSIZE=24&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Ablynx%20nv&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3949829&THISHREF=http://c.moreover.com/click/here.pl%3fz2489336257%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comSharenet: Ablynx Successfully Generates Nanobodies Against an Ion Channel and Announces New GPCR Programmehttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3906524&HITNO=8&MSIZE=24&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Ablynx%20nv&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3906524&THISHREF=http://c.moreover.com/click/here.pl%3fz2466951543%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3906524&HITNO=8&MSIZE=24&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Ablynx%20nv&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3906524&THISHREF=http://c.moreover.com/click/here.pl%3fz2466951543%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comBionity.com: Ablynx Successfully Generates Nanobodies Against An Ion Channel And Announces New Gpcr Programmehttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3890415&HITNO=9&MSIZE=24&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Ablynx%20nv&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3890415&THISHREF=http://c.moreover.com/click/here.pl%3fz2459191905%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3890415&HITNO=9&MSIZE=24&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Ablynx%20nv&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3890415&THISHREF=http://c.moreover.com/click/here.pl%3fz2459191905%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comPharma Live: Ablynx Successfully Generates Nanobodies(R) Against an Ion Channel and Announces New GPCR Programmehttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3889486&HITNO=10&MSIZE=24&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Ablynx%20nv&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3889486&THISHREF=http://c.moreover.com/click/here.pl%3fz2458766859%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3889486&HITNO=10&MSIZE=24&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Ablynx%20nv&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3889486&THISHREF=http://c.moreover.com/click/here.pl%3fz2458766859%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comGenetic Engineering News: Ablynx Successfully Generates NanobodiesR Against an Ion Channel and Announces New GPCR Programmehttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3888117&HITNO=11&MSIZE=24&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Ablynx%20nv&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3888117&THISHREF=http://c.moreover.com/click/here.pl%3fz2458309890%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3888117&HITNO=11&MSIZE=24&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Ablynx%20nv&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3888117&THISHREF=http://c.moreover.com/click/here.pl%3fz2458309890%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comBioPortfolio: Ablynx Announces Webcast Of Its Presentation At The 28th Annual J.P. Morgan Healthcare Conferencehttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3867315&HITNO=12&MSIZE=24&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Ablynx%20nv&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3867315&THISHREF=http://c.moreover.com/click/here.pl%3fz2447121769%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3867315&HITNO=12&MSIZE=24&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Ablynx%20nv&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3867315&THISHREF=http://c.moreover.com/click/here.pl%3fz2447121769%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comPharma Live: ABLYNX ANNOUNCES WEBCAST OF ITS PRESENTATION AT THE 28TH ANNUAL J.P. MORGAN HEALTHCARE CONFERENCEhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3866809&HITNO=13&MSIZE=24&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Ablynx%20nv&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3866809&THISHREF=http://c.moreover.com/click/here.pl%3fz2446848069%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3866809&HITNO=13&MSIZE=24&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Ablynx%20nv&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3866809&THISHREF=http://c.moreover.com/click/here.pl%3fz2446848069%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comIndividual.com: ABLYNX ANNOUNCES WEBCAST OF ITS PRESENTATION AT THE 28TH ANNUAL J.P. MORGAN HEALTHCARE CONFERENCEhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3866805&HITNO=14&MSIZE=24&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Ablynx%20nv&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3866805&THISHREF=http://c.moreover.com/click/here.pl%3fz2446847363%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3866805&HITNO=14&MSIZE=24&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Ablynx%20nv&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3866805&THISHREF=http://c.moreover.com/click/here.pl%3fz2446847363%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comIndividual.com: